Search research articles
Contact Us
Filters
Showing results (141-150 of 175) with videos related to
Page
of 18
Sort By:
Cancer Discovery
|
January 19, 2024
EGFR-driven lung adenocarcinomas coopt alveolar macrophage metabolism and function to support EGFR signaling and growth
Alexandra Kuhlmann-Hogan, Thekla Cordes, Ziyan Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 18, 2021
A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non-Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1
Sarah A Weiss, Dijana Djureinovic, Shlomit Jessel, et al.
Cancer Discovery
|
January 25, 2024
EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Alexandra Kuhlmann-Hogan, Thekla Cordes, Ziyan Xu, et al.
Gastro Hep Advances
|
October 24, 2022
Eicosanoids in the pancreatic tumor microenvironment - a multicellular, multifaceted progression
Vikas B Gubbala, Nidhi Jytosana, Vincent Q Trinh, et al.
Nature Immunology
|
November 8, 2005
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
Andrew M Intlekofer, Naofumi Takemoto, E John Wherry, et al.
Immunity
|
August 12, 2023
CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma
Dan Chen, Siva Karthik Varanasi, Toshiro Hara, et al.
Nature Immunology
|
October 27, 2014
A central role for Notch in effector CD8(+) T cell differentiation
Ronald A Backer, Christina Helbig, Rebecca Gentek, et al.
Biorxiv : the Preprint Server for Biology
|
February 12, 2026
The CD8 immgenT framework as a universal reference of mouse CD8αβ T cell differentiation states
Giovanni Galletti, Anna-Maria Globig, Olga Barreiro, et al.
Oncotarget
|
June 15, 2018
Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response
Felipe V Pereira, Amanda Campelo L Melo, Jun Siong Low, et al.
Molecular Cancer
|
November 15, 2023
A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better
Dijana Djureinovic, Sarah A Weiss, Irina Krykbaeva, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 175) with videos related to
Sort By:
Page
of 18
Cancer Discovery
|
January 19, 2024
EGFR-driven lung adenocarcinomas coopt alveolar macrophage metabolism and function to support EGFR signaling and growth
Alexandra Kuhlmann-Hogan, Thekla Cordes, Ziyan Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 18, 2021
A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non-Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1
Sarah A Weiss, Dijana Djureinovic, Shlomit Jessel, et al.
Cancer Discovery
|
January 25, 2024
EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Alexandra Kuhlmann-Hogan, Thekla Cordes, Ziyan Xu, et al.
Gastro Hep Advances
|
October 24, 2022
Eicosanoids in the pancreatic tumor microenvironment - a multicellular, multifaceted progression
Vikas B Gubbala, Nidhi Jytosana, Vincent Q Trinh, et al.
Nature Immunology
|
November 8, 2005
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
Andrew M Intlekofer, Naofumi Takemoto, E John Wherry, et al.
Immunity
|
August 12, 2023
CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma
Dan Chen, Siva Karthik Varanasi, Toshiro Hara, et al.
Nature Immunology
|
October 27, 2014
A central role for Notch in effector CD8(+) T cell differentiation
Ronald A Backer, Christina Helbig, Rebecca Gentek, et al.
Biorxiv : the Preprint Server for Biology
|
February 12, 2026
The CD8 immgenT framework as a universal reference of mouse CD8αβ T cell differentiation states
Giovanni Galletti, Anna-Maria Globig, Olga Barreiro, et al.
Oncotarget
|
June 15, 2018
Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response
Felipe V Pereira, Amanda Campelo L Melo, Jun Siong Low, et al.
Molecular Cancer
|
November 15, 2023
A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better
Dijana Djureinovic, Sarah A Weiss, Irina Krykbaeva, et al.
Page
of 18